₹ 226.95
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Based in Mumbai, India, Auro Laboratories Ltd. commenced operations on May 26, 1989. The company primarily deals in active pharmaceutical ingredients (APIs) and also supplies bulk drugs.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITD
Data is available to registered users only